查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球磊晶市場：市場規模、佔有率、趨勢分析、機會和預測（2019-2030）
市場調查報告書
商品編碼
1410997

全球磊晶市場：市場規模、佔有率、趨勢分析、機會和預測（2019-2030）

Epigenetics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Product ; By Technology ; By Application ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球磊晶市場規模預計將以 15.2% 的複合年成長率成長一倍以上，到 2030 年達到 54.7 億美元。

報告顯示，由於人們越來越關注癌症盛行率上升的治療和管理、醫療保健領域研發活動的加強以及個人化醫療範圍的擴大，全球磊晶市場正在蓬勃發展。

領先的策略諮詢和市場研究公司 BlueWeave Consulting 在最近的一項研究中估計，2023 年全球磊晶市場規模將達到 23.4 億美元。 BlueWeave 預測，在 2024 年至 2030 年的預測期內，全球磊晶市場規模將以 15.20% 的複合年成長率成長，到 2030 年將達到 54.7 億美元。包括癌症和心血管疾病在內的慢性病盛行率不斷上升，以及藥物研發的不斷增加是全球磊晶市場的關鍵驅動力。此外，在整個預測期內，對標靶藥物開發和客製化醫療的日益重視預計將為全球磊晶市場的參與者提供重大機會。

該報告的詳細分析提供了有關成長潛力、未來趨勢和全球磊晶市場的資訊。它還重點關注推動市場總規模預測的因素。該報告致力於提供全球磊晶市場的最新技術趨勢和產業見解，以幫助決策者做出明智的策略決策。此外，我們也分析了市場的成長動力、挑戰和競爭力。

目錄

第1章 研究框架

第 2 章執行摘要

第3章全球磊晶市場洞察

  • 產業價值鏈分析
  • DROC分析
    • 生長促進因子
      • 慢性病盛行率上升
      • 磊晶技術的進展
      • 增加磊晶研究的投資
    • 抑制因素
      • 資料隱私問題
      • 磊晶技術的成本
    • 機會
      • 個人化醫療的發展
      • 新應用的開發
    • 任務
      • 監管障礙
      • 缺乏標準化
  • 科技進步/最新發展
  • 消費者行為與洞察
  • 法律規範
  • 波特五力分析

第4章全球磊晶市場概述

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
      • 試劑
      • 套件
      • 晶片測序套件
      • 全基因組擴增套件
      • 亞硫酸氫鹽轉換套件
      • RNA定序試劑套件
      • 其他
      • 裝置
      • 酵素
      • 服務
    • 依技術
      • DNA甲基化
      • 組蛋白甲基化
      • 組蛋白乙醯化
      • 大非編碼RNA
      • 微小RNA修飾
      • 染色質結構
    • 按用途
      • 腫瘤學
      • 固態腫瘤
      • 液體腫瘤
      • 非腫瘤學
      • 發炎疾病
      • 代謝性疾病
      • 感染疾病
      • 心血管疾病
      • 其他
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區 (APAC)
      • 拉丁美洲 (LATAM)
      • 中東和非洲 (MEA)

第5章北美磊晶市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 依技術
    • 按用途
    • 按國家/地區
      • 美國
      • 加拿大

第6章歐洲磊晶市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 依技術
    • 按用途
    • 按國家/地區
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 其他歐洲國家

第7章亞太表觀磊晶市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 依技術
    • 按用途
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳洲和紐西蘭
      • 印尼
      • 馬來西亞
      • 新加坡
      • 越南
      • 其他亞太地區

第8章拉丁美洲磊晶市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 依技術
    • 按用途
    • 按國家/地區
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 其他拉丁美洲

第9章中東和非洲磊晶市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 依技術
    • 按用途
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 科威特
      • 南非
      • 奈及利亞
      • 阿爾及利亞
      • 其他中東/非洲

第10章競爭形勢

  • 主要企業及其產品列表
  • 2023 年全球磊晶市場佔有率分析
  • 透過管理參數進行競爭基準化分析
  • 主要策略發展（合併、收購、合作夥伴關係等）

第11章地緣政治緊張局勢加劇對全球磊晶市場的影響

第12章 公司簡介（公司簡介、財務矩陣、競爭形勢、關鍵人力資源、主要競爭對手、聯絡地址、策略展望、SWOT分析）

  • Qiagen
  • Thermo Fisher Scientific
  • Illumina
  • Agilent Technologies
  • Zymo Research
  • Clontech
  • New England Biolabs（NEB）
  • EpigenTek Group Inc.
  • Active Motif
  • Diagenode
  • 其他主要企業

第13章 主要戰略建議

第14章調查方法

簡介目錄
Product Code: BWC24035

Global Epigenetics Market Size More Than Doubles at Robust CAGR of 15.2%, to Reach USD 5.47 Billion by 2030.

Global Epigenetics Market is flourishing because of and increasing focus on the treatment and management of rising prevalence of cancer and intensifying R&D activities in the healthcare sector, along with expanding scope of personalized medicine.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Epigenetics Market size at USD 2.34 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Epigenetics Market size to expand at a CAGR of 15.20% reaching a value of USD 5.47 billion by 2030. The growing prevalence of chronic illnesses, including cancer and cardiovascular diseases, as well as an increase in pharmaceutical research and development are significant driving factors for the Global Epigenetics Market. Moreover, throughout the projected period, the development of targeted medicines and a growing emphasis on customized medicine are expected to provide substantial opportunities for players in the Global Epigenetic Market.

Opportunity: Advanced research and development activities

With the rising prevalence of various chronic diseases, various pharmaceutical and biotechnology companies are increasing their investments in R&D programs to make advancements in epigenetics and expand its application in non-oncology segments as well. A recent study published in the scientific journal Nature explores the epigenetic changes in cancer progression as well as identifies the cellular pathways of these genes that may potentially prove crucial in developing strategies for maximizing the therapeutic benefits while minimizing the side effects. Positive outcomes from research and development activities are anticipated to provide lucrative growth opportunities for companies in the Global Epigenetics Market over the forecast period.

Impact of Escalating Geopolitical Tensions on Global Epigenetics Market

The escalating geopolitical tensions hampered the growth of the global epigenetics market. For instance, Ukraine is one of the leading healthcare providers and engages in extensive research and development activities. However, after Russia attacked Ukraine in February 2022, the healthcare and clinical infrastructure of Ukraine were impacted. Patients from abroad as well as those within Ukraine experienced difficulties accessing healthcare resources due to the regional unrest in the country, especially in the Kyiv region. Research collaborations and international partnerships in clinical research may be put under pressure after the situation in Ukraine, which might impede advancements in the sector. Essentially, these geopolitical tensions highlight the necessity for strategic adaptability and resilience in navigating these challenging conditions by introducing uncertainties and obstacles across all aspects of the epigenetics business.

Global Epigenetics Market

Segmental Coverage

Global Epigenetics Market - By Technology

Based on technology, the Global Epigenetics Market is segmented into DNA Methylation, Histone Methylation, Histone Acetylation, Large Non-Coding RNA, MicroRNA Modification, and Chromatin Structures. DNA methylation technology holds the largest share in the Global Epigenetics Market. According to a report published in The Lancet, with tissue-specific variations, methylation may be utilized in a basic cell-free circulating-DNA blood test to identify cell death and track several prevalent diseases. Additionally, it demonstrates the enormous potential for disease diagnosis, customized treatment, and prevention.

Global Epigenetics Market - By Region

The in-depth research report on the Global Epigenetics Market covers the market in a major number of countries across five regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Epigenetics Market. Accessible healthcare services, along with advanced medical infrastructure, act as a major driving factor for market growth in the region. Moreover, extensive research and development activities surrounding epigenetics, owing to the high concentration of leading pharmaceutical companies and favorable government support, contribute to the epigenetics market growth in North America.

Competitive Landscape

Major players operating in the Global Epigenetics Market include: Qiagen, Thermo Fisher Scientific, Illumina, Agilent Technologies, Zymo Research, Clontech, New England Biolabs (NEB), EpigenTek Group Inc., Active Motif, and Diagenode. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Epigenetics Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Epigenetics Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Epigenetics Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rising Prevalence of Chronic Diseases
      • 3.2.1.2. Advances in Epigenetic Technologies
      • 3.2.1.3. Increasing Investment in Epigenetics Research
    • 3.2.2. Restraints
      • 3.2.2.1. Data Privacy Concerns
      • 3.2.2.2. Cost of Epigenetic Technologies
    • 3.2.3. Opportunities
      • 3.2.3.1. Development of Personalized Medicine
      • 3.2.3.2. Expansion into New Applications
    • 3.2.4. Challenges
      • 3.2.4.1. Regulatory Hurdles
      • 3.2.4.2. Lack of Standardization
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Consumer Behavior and Insights
  • 3.5. Regulatory Framework
  • 3.6. Porter's Five Forces Analysis
    • 3.6.1. Bargaining Power of Suppliers
    • 3.6.2. Bargaining Power of Buyers
    • 3.6.3. Threat of New Entrants
    • 3.6.4. Threat of Substitutes
    • 3.6.5. Intensity of Rivalry

4. Global Epigenetics Market Overview

  • 4.1. Market Size & Forecast, 2019-2030
    • 4.1.1. By Value (USD Billion)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Reagents
      • 4.2.1.2. Kits
      • 4.2.1.2.1. Chip Sequencing Kit
      • 4.2.1.2.2. Whole Genomic Amplification Kit
      • 4.2.1.2.3. Bisulfite Conversion Kit
      • 4.2.1.2.4. RNA Sequencing Kit
      • 4.2.1.2.5. Others
      • 4.2.1.3. Instruments
      • 4.2.1.4. Enzymes
      • 4.2.1.5. Services
    • 4.2.2. By Technology
      • 4.2.2.1. DNA Methylation
      • 4.2.2.2. Histone Methylation
      • 4.2.2.3. Histone Acetylation
      • 4.2.2.4. Large Non - Coding RNA
      • 4.2.2.5. MicroRNA Modification
      • 4.2.2.6. Chromatin Structures
    • 4.2.3. By Application
      • 4.2.3.1. Oncology
      • 4.2.3.1.1. Solid Tumors
      • 4.2.3.1.2. Liquid Tumors
      • 4.2.3.2. Non - Oncology
      • 4.2.3.2.1. Inflammatory Diseases
      • 4.2.3.2.2. Metabolic Diseases
      • 4.2.3.2.3. Infectious Diseases
      • 4.2.3.2.4. Cardiovascular Diseases
      • 4.2.3.2.5. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Epigenetics Market

  • 5.1. Market Size & Forecast, 2019-2030
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Technology
    • 5.2.3. By Application
    • 5.2.4. By Country
      • 5.2.4.1. United States
      • 5.2.4.1.1. By Product
      • 5.2.4.1.2. By Technology
      • 5.2.4.1.3. By Application
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Product
      • 5.2.4.2.2. By Technology
      • 5.2.4.2.3. By Application

6. Europe Epigenetics Market

  • 6.1. Market Size & Forecast, 2019-2030
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Product
      • 6.2.4.1.2. By Technology
      • 6.2.4.1.3. By Application
      • 6.2.4.2. United Kingdom
      • 6.2.4.2.1. By Product
      • 6.2.4.2.2. By Technology
      • 6.2.4.2.3. By Application
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Product
      • 6.2.4.3.2. By Technology
      • 6.2.4.3.3. By Application
      • 6.2.4.4. France
      • 6.2.4.4.1. By Product
      • 6.2.4.4.2. By Technology
      • 6.2.4.4.3. By Application
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Product
      • 6.2.4.5.2. By Technology
      • 6.2.4.5.3. By Application
      • 6.2.4.6. Belgium
      • 6.2.4.6.1. By Product
      • 6.2.4.6.2. By Technology
      • 6.2.4.6.3. By Application
      • 6.2.4.7. Russia
      • 6.2.4.7.1. By Product
      • 6.2.4.7.2. By Technology
      • 6.2.4.7.3. By Application
      • 6.2.4.8. The Netherlands
      • 6.2.4.8.1. By Product
      • 6.2.4.8.2. By Technology
      • 6.2.4.8.3. By Application
      • 6.2.4.9. Rest of Europe
      • 6.2.4.9.1. By Product
      • 6.2.4.9.2. By Technology
      • 6.2.4.9.3. By Application

7. Asia Pacific Epigenetics Market

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Product
      • 7.2.4.1.2. By Technology
      • 7.2.4.1.3. By Application
      • 7.2.4.2. India
      • 7.2.4.2.1. By Product
      • 7.2.4.2.2. By Technology
      • 7.2.4.2.3. By Application
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Product
      • 7.2.4.3.2. By Technology
      • 7.2.4.3.3. By Application
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Product
      • 7.2.4.4.2. By Technology
      • 7.2.4.4.3. By Application
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Product
      • 7.2.4.5.2. By Technology
      • 7.2.4.5.3. By Application
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Product
      • 7.2.4.6.2. By Technology
      • 7.2.4.6.3. By Application
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Product
      • 7.2.4.7.2. By Technology
      • 7.2.4.7.3. By Application
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Product
      • 7.2.4.8.2. By Technology
      • 7.2.4.8.3. By Application
      • 7.2.4.9. Vietnam
      • 7.2.4.9.1. By Product
      • 7.2.4.9.2. By Technology
      • 7.2.4.9.3. By Application
      • 7.2.4.10. Rest of APAC
      • 7.2.4.10.1. By Product
      • 7.2.4.10.2. By Technology
      • 7.2.4.10.3. By Application

8. Latin America Epigenetics Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Product
      • 8.2.4.1.2. By Technology
      • 8.2.4.1.3. By Application
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Product
      • 8.2.4.2.2. By Technology
      • 8.2.4.2.3. By Application
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Product
      • 8.2.4.3.2. By Technology
      • 8.2.4.3.3. By Application
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Product
      • 8.2.4.4.2. By Technology
      • 8.2.4.4.3. By Application
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Product
      • 8.2.4.5.2. By Technology
      • 8.2.4.5.3. By Application

9. Middle East & Africa Epigenetics Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Product
      • 9.2.4.1.2. By Technology
      • 9.2.4.1.3. By Application
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Product
      • 9.2.4.2.2. By Technology
      • 9.2.4.2.3. By Application
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Product
      • 9.2.4.3.2. By Technology
      • 9.2.4.3.3. By Application
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Product
      • 9.2.4.4.2. By Technology
      • 9.2.4.4.3. By Application
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Product
      • 9.2.4.5.2. By Technology
      • 9.2.4.5.3. By Application
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Product
      • 9.2.4.6.2. By Technology
      • 9.2.4.6.3. By Application
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Product
      • 9.2.4.7.2. By Technology
      • 9.2.4.7.3. By Application
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Product
      • 9.2.4.8.2. By Technology
      • 9.2.4.8.3. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Epigenetics Market Share Analysis, 2023
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Escalating Geopolitical Tensions on Global Epigenetics Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 12.1. Qiagen
  • 12.2. Thermo Fisher Scientific
  • 12.3. Illumina
  • 12.4. Agilent Technologies
  • 12.5. Zymo Research
  • 12.6. Clontech
  • 12.7. New England Biolabs (NEB)
  • 12.8. EpigenTek Group Inc.
  • 12.9. Active Motif
  • 12.10. Diagenode
  • 12.11. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations